Rebuilding Choice Architecture for Incurable but Treatable Lung Cancer: Rethinking the Future of Hospice Care in the United States
By Maggie Salinger, MD, MPP, and Arif Kamal, MD MBA, MHS, FAAHPM, FASCO Posted: December 11, 2019 IN REFERENCE TO: Mor V, Wagner TH, Levy C, et al. Association of […] Read more
By Leah Lawrence Posted: December 11, 2019 Many patients newly diagnosed with lung cancer have difficulty navigating the world of cancer when unexpectedly and unwillingly thrust into it. In addition […] Read more
By Anjali Saqi, MD, MBA; Deepali Jain, MD, FIAC; Lukas Bubendorf, MD; Keith Kerr, MB, ChB, MRCPath, FRCPath, FRCP(Ed); and Andre Moreira, MD, PhD Posted: December 11, 2019 Lung cancer […] Read more
STARS Patient Research Advocate Training Program Seeks Patients and Caregivers
By Adam Mohrbacher Posted: December 11, 2019 Patients with lung cancer and their caregivers are becoming more empowered and knowledgeable than ever. As a result, lung cancer now has a […] Read more
By Suresh Ramalingam, MD Posted: December 11, 2019 IN REFERENCE TO: Garon EB, Hellmann MD, Rizvi NA, et al. Five-Year Overall Survival for Patients With Advanced Non–Small-Cell Lung Cancer Treated […] Read more
From Patient to Patient Research Advocate: The STARS Journey
By Adam Mohrbacher Posted: December 11, 2019 With the rise of organized lung cancer patient advocacy groups,1 patients, advocates, and caregivers are now playing a larger role than ever in […] Read more
Lung Cancer Leading the Charge for Tumor-Agnostic Targeted Therapies
By Robert C. Doebele, MD, PhD Posted: December 11, 2019 Dr. Robert C. Doebele Early in the drug development of targeted therapies, specific oncogene mutations were often associated with a […] Read more
First-Ever IASLC School of Nursing Held at Latin American Lung Cancer Regional Meeting in Mexico City
By Enza Esposito Nguyen, DNP Posted: December 11, 2019 Dr. Enza Esposito Nguyen The IASLC held its ninth Latin American Lung Cancer (LALCA) regional meeting in Mexico City this past […] Read more
Novel Insights on ctDNA Dynamics During Targeted Therapy and Immune Checkpoint Blockage in NSCLC
By Christian Rolfo, MD, PhD, MBA, Dr.h.c. Posted: December 11, 2019 IN REFERENCE TO: Phallen J, Leal A, Woodward BD, et al. Early Noninvasive Detection of Response to Targeted Therapy […] Read more
By Luis E. Raez, MD, FACP, FCCP Posted: December 11, 2019 The 8th IASLC Latin American Conference in Lung Cancer (LALCA) was held in Mexico City, Mexico, from October 18 […] Read more